fashion -WSS

fashion

author：fashion 2025-09-06 04:27:16 - browse：37

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Microbiome research is starting to find links to chronic diseases

hotspot

WSS

Johnson & Johnson sues to stop Medicare negotiation

UK homeowners get some respite as inflation falls by more than anticipated to a 15

FDA panel to weigh approval of NurOwn, controversial ALS drug

CDC advisers recommend seasonal use of Pfizer RSV shot

Why are Kaiser Permanente staff considering a strike?

A Theranos scientist

focus

fashion

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Twill hunts for pharma partner to market its depression app

As demand for Covid shots wanes, Moderna seeks its next success

ER docs worry over extreme heat as a 'mass casualty event'

Supreme Court strikes down use of affirmative action

Twill hunts for pharma partner to market its depression app

Supreme Court strikes down use of affirmative action

Thermo Fisher plant for manufacturing gene therapies to expand

State Dept. review finds Biden bears some blame for Afghanistan failures

Senate HELP committee spars over health care workforce policies

focus

Robert Kennedy Jr.'s presidential campaign attracts GOP

Readout LOUD podcast: possible new ALS drug, artificial wombs

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Why you get paid to donate plasma but not blood

What we know about the American soldier detained in North Korea

Ukraine and a new approach to mental health in war

focus

hotspot

hotspot

hotspot